Your SlideShare is downloading. ×
Elimination of occupational cancer from hazardous substances
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Elimination of occupational cancer from hazardous substances

3,451
views

Published on

The Jeffrey S Lee presentation given at the American Industrial Hygiene conference (AIHce) in Indianapolis, June 2012.

The Jeffrey S Lee presentation given at the American Industrial Hygiene conference (AIHce) in Indianapolis, June 2012.

Published in: Health & Medicine

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
3,451
On Slideshare
0
From Embeds
0
Number of Embeds
21
Actions
Shares
0
Downloads
32
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Stress that this is due to continuous improvement not H&S interventions
  • The mostextreme reduction is from the PVC plants in the early 1970s when the risk of angiosarcoma of the liver was first identified as a consequence of high VCM exposure. Here over a about a year the exposure dropped by more that an order of magnitude. Interestingly, although there was not systematic monitoring data for the period prior to the dramatic change the evidence is that there were improvements taking place before this which would have given a series of modest reductions in exposure and after about 1975 the rate of decline in exposure again dropped to about 6% per annum.
  • Transcript

    • 1. WORKING FOR A HEALTHY FUTUREElimination of occupational cancerfrom hazardous substancesJohn CherrieINSTITUTE OF OCCUPATIONAL MEDICINE . Edinburgh . UK www.iom-world.org
    • 2. Jeffrey Lee• 32-year ACGIH member, he gave generously gave his time and talents to various committees and to the Board of Directors in 1987–88• Helped establish the journal, Applied Occupational and Environmental Hygiene, and served as its Editor-in- Chief from 1990–1993
    • 3. Summary…• Workplace cancers are a concern• The current occupational cancer burden is mostly caused by a small number of agents• Exposures have been decreasing steadily over time• Without any additional actions burden in the future will be lower than now• Focused effort could ensure the occupational cancer burden becomes much less than 1% of all cancers• This would “eliminate” workplace cancer
    • 4. Europe’s dirtiest factory…• Malcolm Carhart died from lung cancer• Fred Richards had bladder cancer and survived• 300 other men who worked at the Phurnacite plant in South Wales had their health damaged by their work Mr Fred Richards
    • 5. This was a coal carbonization plant
    • 6. Mortality in the plant…• We carried out a mortality study in the plant in 1987 • 17 year follow-up • 620 men included• Increased mortality Lung Stomach Prostate Bladder Pneumonia COPD SMR 146 160 152 270 189 139• Non-melanoma skin cancer commonly reported
    • 7. President Richard Nixon started a war• 23rd December 1971 he signed the National Cancer Act• The main focus was on trying to find a cure, but there was a clear focus on prevention• Strengthened the role of NCI• This was the “War on Cancer”
    • 8. Doll and Peto assessed cancer burden• In 1981, they were commission by the US government to assess the relative importance of the “environment” in causing cancer• Their aim was to identify the proportion of cancer that is preventable
    • 9. Typical US Low incidence75% and 80% of all cancers are preventable Connecticut Low incidence registry
    • 10. Attributable fractions… About 4% (2 – 8%)
    • 11. Cancer burden in the UK…• Designed to update Doll and Peto’s estimate for occupational cancer burden • Current burden (2010) • Future burden (to 2060)• Method based on: • Risk of Disease (relative risk from published literature) • Proportion of Population Exposed• Estimation for IARC groups 1 (definite) and 2A (probable) carcinogens and occupational circumstances
    • 12. Attributable fraction… Men = blue Women = red 5.3% (4.6 – 6.6%)
    • 13. Cancer registrations… 85% of the cancer cases come from the top ten chemical agents - excluding ETS, which is already banned
    • 14. Exposure decreases over time… Aerosols Creely KS et al. (2007) Trends in inhalation exposure--a review of the data in the published scientific literature. Ann OccupHyg.; 51(8): 665-678.
    • 15. Exposure decreases over time… Gases and vapours Creely KS et al. (2007) Trends in inhalation exposure--a review of the data in the published scientific literature. Ann OccupHyg.; 51(8): 665-678.
    • 16. VCM levels in a English PVC plant 1000 y = 2E+30e-2.00x VCM concentration (ppm) R² = 0.740 100 10 1 1973 1974 1975 16
    • 17. Burden should be decreasing…• If exposure is decreasing then it seems likely that the future burden will also be lower• Assumes • Risk is related to exposure • Prevalence of exposure is not increasing • The aging population is not distorting the picture
    • 18. So what does the future hold?• We have estimated future cancer burden in Europe and socioeconomic costs of interventions for a number of carcinogens • Exposure levels reliant on stakeholder data or when unavailable published sources • Risk assessment reliant on epidemiological studies or analogy • Health impact carried out using carefully reviewed methodology developed for British cancer burden study • Socioeconomic assessment based on EC guidance
    • 19. Estimates of future burden…• Crystalline silica in Europe as an example: • 720,000 people exposed in Europe • 41% exposed above 0.05 mg/m3 • Current burden 7,600 lung cancers • 460,000 cases between 2010 and 2069 • Cost of inaction between €190,000m to €490,000m
    • 20. Lung cancer registrations - baseline
    • 21. Lung cancer registrations - intervention
    • 22. The cost and benefits of intervention…• Total net health benefits by 2069 from setting an OEL at 0.05 mg/m3 are €28,000m to €74,000m• Costs of compliance estimated to be €34,000m • About half of these costs arise in construction • Most costs fall on small companies
    • 23. However, we could just wait…
    • 24. What would “eliminate” really mean?• Elimination of the disease as a public health problem (i.e. reduction of cases below what is considered to be a public health risk)• What might be “a public health risk” for occupational cancer?• Reduction of incidence to <<1% of all cancers?
    • 25. For some substances we are already there• In our assessment of current burden in Europe we estimate <20 cancers/year from past exposure for: • Vinyl chloride monomer 14 cases • 1, 3 Butadiene 2 cases • Beryllium 7 cases • Acrylamide 7 cases • MbOCA 8 cases • Ethylene oxide 0 cases • Refractory ceramic fibre 2 cases • 1, 2-Epoxypropane 0 cases • Bromoethylene 0 cases
    • 26. Tracking progress…• Periodic surveys of exposure by EU and national authorities • Intensity (including contextual information) • Prevalence• Updates of cancer burden estimates• Routine reporting by occupational hygienists through European occupational hygiene associations
    • 27. A challenge…• Focus on the top ten causes of the occupational cancer burden• Ensure that exposures continue to fall by about 10% per annum• We have eliminated the problem when an assessment of future burden from current exposure is <1% of all cancers
    • 28. Acknowledgements…• The work was in part funded by the British Health and Safety Executive (HSE) and the European Commission (EC)• However, the views presented here are my own• Collaborators include: • M Gorman Ng, A Shafrir, M van Tongeren, A Searl, J Crawford, A Sanchez-Jimenez, J Lamb (IOM) • R Mistry, M Sobey, C Corden, O Warwick and M-H Bouhier (AMEC UK) • L Rushton and S Hutchings (Imperial College) • T Kaupinnen and P Heikkila (Finnish Institute of Occupational Health), H Kromhout (IRAS, University of Utrecht) • L Levy (IEH, Cranfield University)
    • 29. Questions…• You can contribute to the discussion at www.OH- world.org John.Cherrie@iom-world.org